Global Tuberculosis Diagnostics and Treatment Markets

    Published: June 1, 2007 | Price: $995.00 – $1,990.00

    The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles. As illustrated by Kenneth G. Krul, Phd., in Kalorama Information's Global Tuberculosis Strategies, there are abundant opportunities for diagnostic and pharmaceutical companies in combating the global tuberculosis threat. As the author details, there are primarily three focal...
    Early Toxicology – Markets and Approaches

    Published: June 1, 2007 | Price: $1,990.00 – $6,990.00

    Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient responses also differ widely, depending on their age and metabolism and other products in the patient’s system may augment the effect of the drug. Just twenty years ago, toxicology was something that...
    Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments – World Market

    Published: May 1, 2007 | Price: $995.00 – $3,990.00

    Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market from Kalorama Information. One of the most promising new approaches in modern cancer treatment is immunotherapy, the development of methods to augment and enhance the...
    U.S. Market for Home Care Products, 5th Edition

    Published: May 1, 2007 | Price: $2,995.00 – $7,990.00

    This study The U.S. Market for Home Care Products, 5th Edition represents the fifth time Kalorama Information has investigated this growing market over the past 12 years. The U.S. market for home care products and equipment continues to post steady gains, primarily as a result of the aging population and increasing shifts of chronic care patients from hospitals to home. Serious market watchers will want to keep aware of trends in this industry, major players and market data. In 2006,...
    Asian Medical Device Markets (Medical Devices in China, India, Japan, South Korea and Australia)

    Published: May 1, 2007 | Price: $1,995.00 – $7,990.00

    Companies seeking increased revenue for their products cannot ignore the Asian Medical Device Market. Although Asia Pacific as a region was the smallest healthcare market out of the three major geographic regions (US, Europe, and Asia Pacific), rising income and with it, continued growth in healthcare spending makes Asia an important market for makers of medical devices. Kalorama Information's Asian Medical Device Markets is your guide to the market for medical devices in 5 key markets: Australia Japan South Korea...
    Anti-Infectives – World Market, 2nd Edition, Vol III – Antivirals

    Published: May 1, 2007 | Price: $2,700.00 – $5,990.00

    This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides: Revenue Data by Infection Type An overview of products on the market Review of products in the development pipeline Market estimates and forecasts through 2011 Market segmentation by geographic region...
    Physician Office Laboratory (POL) Testing Markets Worldwide – Status Quo and Future Trends

    Published: May 1, 2007 | Price: $2,995.00 – $5,990.00

    Many in the clinical and manufacturing community have their eyes on the Physician Office Laboratory (POL) as an outlet both to improve patient compliance and outcomes and to open new market opportunities. Studies are emerging on the clinical outcomes and cost-benefit of nearer-the-patient testing, but little certain is known about POLs as a distribution channel for diagnostics products. Kalorama's Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends takes a bold look into the technologies and trends...
    Medical Imaging Markets, Volume V – Molecular Imaging

    Published: May 1, 2007 | Price: $2,995.00 – $5,990.00

    Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease. The final volume in Kalorama's Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the...
    Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

    Published: April 1, 2007 | Price: $4,995.00 – $9,990.00

    Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. Kalorama's Drug Delivery Systems focuses on these technologies. This offer is for the entire 4 volumes of Kalorama's 2nd edition of its Drug Delivery Markets series, covering all major types, including: Oral Delivery Implantable/Injectable Pulmonary Transdermal/Transmucosal While oral delivery remains the most popular and...
    Smoking Cessation and Addiction Treatments: A World Market Analysis

    Published: April 1, 2007 | Price: $1,295.00 – $2,995.00

    SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking cessation aids. The market, which Zyban currently holds a tenuous lock on, is about to change, with a major new brand ready to shake up the current market share. At the...
    Implant-Based Dental Reconstruction: The Worldwide Dental Implant and Bone Graft Market, 2nd Edition

    Published: April 1, 2007 | Price: $3,995.00 – $7,990.00

    There is an important development occuring in the dental implant industry; one that opens up the procedure to new patients and provides new revenue opportunities. Dental implant systems are fast becoming the preferred restoration for replacement of missing or extracted teeth or as as supports for dentures, crowns and bridges. But poor bone quality eliminated a number of patients. New bone graft procedures are changing that, and have expanded the candidate pool for implants to include a sizable population of...
    Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery

    Published: April 1, 2007 | Price: $2,495.00 – $4,990.00

    New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. Kalorama's Drug Delivery Markets Series covers these new systems. The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechanism that offers some advantages: low pain, infection risk, fewer...
    Anti Infectives: World Market, 2nd Edition, Vol II: Antibacterials

    Published: April 1, 2007 | Price: $2,995.00 – $5,990.00

    The market for antibiotics has changed and a knowledge of the current drug resistance situation is critical before operating in this marketplace. The effectiveness of many antibacterials (antibiotics) is being reduced as more and more types of bacteria become resistant to them. These and other developments are covered in Kalorama's Anti-Infectives, World Markets, Vol. II: Antibacterials providing extensive detail on the anti-bacterial market, including the following critical trends: Drug resistance and Interactions Antibiotic Abuse Antibiotic Cycling Addressing Market Trends Antibiotic...
    Refractive Vision Correction – A Market Analysis

    Published: March 1, 2007 | Price: $450.00 – $2,990.00

    Since the advent of LASIK nearly two decades ago, refractive vision correction remains a vibrant market impacted by technology. Kalorama's market analysis takes a look at the entire market for non-disease eye treatment procedures. Complete coverage of the vision correction market, including the correction of conditions such as myopia (nearsightedness), presbyobia (an inibility to focus), astigmatism and hyperopia or far-sightedness. Areas of the market covered in the report include:   LASIK Equipment Sales Bladeless LASIK Spacers and RVC Alternatives Phakic...
    Drug Delivery Markets, Vol III – Pulmonary Delivery Systems

    Published: March 1, 2007 | Price: $2,495.00 – $4,990.00

    The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in 2006 and is expected to experience high steady growth in the next five years. Contributing to growth are new technologies such as dry powder inhalers...
    Anti-Infectives – World Market, 2nd. Ed., Vol. I – Antifungals

    Published: March 1, 2007 | Price: $2,500.00 – $5,990.00

    Over one billion people suffer from fungal infections worldwide, and this number is growing Though Athlete's foot, dandruff, vaginal yeast infection and fungal nail make up the bulk of these cases, there has been a steady increase in the incidence of more serious infections. This is partially due to the widespread use of antibiotics, which eliminate or decrease fungi-killing bacteria. The increased number of individuals with reduced immune responses caused by AIDS or the effects of chemotherapy has also been...
    Diabetes: Major World Markets, 3rd Ed. (Diagnostic and Treatment Markets in the US, Germany, Italy, Japan, Spain, UK and France)

    Published: March 1, 2007 | Price: $3,500.00 – $7,990.00

    The market for diabetes-related products is huge and continuing to grow. However, it is not the same market as it was just 3 years ago. New trends in care, new products (both therapeutic and diagnostic), new approaches to long-term complications, and changing public health priorities along with geographic variations are shifting the sands of opportunities in diabetes care. This comprehensive re-evaluation of the major world market for diabetes monitoring and therapeutic products provides in-depth data and analysis including: Detailed epidemiology...
    Lateral Flow Technology and the Future of Point-of-Care Diagnostics

    Published: February 1, 2007 | Price: $1,995.00 – $3,990.00

    Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...
    Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)

    Published: February 1, 2007 | Price: $2,995.00 – $4,990.00

    Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition...
    Cancer Therapeutics: The Worldwide Market , 2nd Edition

    Published: February 1, 2007 | Price: $2,500.00 – $7,990.00

    With over 6,160 individual data points reflecting useful market data, Kalorama's Cancer Therapeutics: The Worldwide Market, 2nd Edition is the most comprehensive and recent information available on the five key cancer therapy and treatment markets in a syndicated market research report, including the following areas: Chemotherapy, including -Subcategories Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives -Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar with Market Share for each Hormone Therapy: -Subcategories include Corticosteroids, Hormone Agonists/Antagonists, Aromatase Inhibitors and SERMS...
    Vaccines – The World Market

    Published: February 1, 2007 | Price: $3,995.00 – $7,990.00

    What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? What makes this class of drugs likely to grow at a faster rate than other pharmaceutical products? These are among the questions answered in Kalorama’s in-depth report, Vaccines: The World Market. With the historic success of vaccines in virtually eliminating diseases such as small pox and polio, and with...
    Medical Imaging Markets, Volume IV – Contrast Agents

    Published: February 1, 2007 | Price: $1,995.00 – $5,990.00

    Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...
    Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition, The

    Published: February 1, 2007 | Price: $3,300.00 – $7,800.00

    With a growing elderly population, premium pricing, and robust new venues, the kidney dialysis and dialysis equipment market approaches $55 billion worldwide and is expected to grow. With those revenues coming from just 1.6 million patients worldwide, kidney dialysis and equipment is among the most lucrative medical treatment markets in per-capita terms. Kalorama’s Worldwide Market for Kidney Dialysis and Equipment is your key to this burgeoning industry. The report breaks down both the 45 billion-dollar dialysis care market and the...
    Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)

    Published: January 1, 2007 | Price: $1,100.00 – $7,800.00

    Wireless technologies and healthcare are a perfect fit. The clinical environment is a highly mobile one, and physicians, nurses and other clinical operators have a real need for fast information and action. With a record of successful implementations across aspects of healthcare from patient care to sales, wireless technologies have moved from conjecture to reality. Hospitals are dedicating large portions of current and future budgets to IT development and wireless is likely to be among their choices. Given these trends,...
    Cell Culture – The World Market for Media, Sera, and Reagents

    Published: January 1, 2007 | Price: $3,900.00 – $7,800.00

    As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report is focused on cell culture used in the research and...
    Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market

    Published: January 1, 2007 | Price: $995.00 – $7,000.00

    The market for psychotherapeutics drugs is about to change dramatically -- and serious pharmaceutical market watchers will want to be prepared. Kalorama’s Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs: World Market is the most exhaustive guide available to this booming market and the direction it is headed in the next four years. Psychotherapeutics treat conditions classified as abnormal behavior, thoughts and feelings that persist for a determined amount of time causing distress or emotional/physical impairment. Depression, anxiety, psychosis, ADHD and nicotine and...
    Biomarkers – A Market Briefing

    Published: January 1, 2007 | Price: $995.00 – $3,990.00

    Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials. Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only...
    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    Published: December 1, 2006 | Price: $4,500.00 – $9,990.00

    The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...
    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    Published: November 1, 2006 | Price: $1,500.00 – $5,990.00

    This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...
    Mass Spectrometry in Protein Biomarker Applications – Software, Services, and Instrument Markets

    Published: November 1, 2006 | Price: $995.00 – $5,990.00

    Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical,...